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Abstract
The malignant glioma is the most common primary human brain tumor. Its tendency to invade away from the primary
tumor mass is considered a leading cause of tumor recurrence and treatment failure. Accordingly, the molecular
pathogenesis of glioma invasion is currently under investigation. Previously, we examined a gene expression array
database comparinghumangliomas tononneoplastic controls and identified several Rac guaninenucleotide exchange
factors with differential expression. Here, we report that the guanine nucleotide exchange factor SWAP-70 has
increased expression in malignant gliomas and strongly correlates with lowered patient survival. SWAP-70 is a multi-
functional signaling protein involved in membrane ruffling that works cooperatively with activated Rac. Using a glioma
tissue microarray, we validated that SWAP-70 demonstrates higher expression in malignant gliomas compared with
low-grade gliomas or nonneoplastic brain tissue. Through immunofluorescence, SWAP-70 localizes to membrane
ruffles in response to the growth factor, epidermal growth factor. To assess the role of SWAP-70 in glioma migration
and invasion,we inhibited its expressionwith small interferingRNAs andobserved decreasedglioma cellmigration and
invasion. SWAP-70 overexpression led to increased levels of active Rac even in low-serum conditions. In addition,
when SWAP-70 was overexpressed in glioma cells, we observed enhanced membrane ruffle formation followed by
increased cell migration and invasiveness. Taken together, our findings suggest that the guanine nucleotide exchange
factor SWAP-70 plays an important role in the migration and invasion of human gliomas into the surrounding tissue.
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Introduction
Malignant gliomas are the most common primary brain tumors in
adults [1]. Despite some recent therapeutic advances in the treatment of
this type of tumor, the overall patient survival rate remains disappoint-
ing. Treatment failures frequently arise from the inability to eliminate
the invading front of tumor cells that extends beyond the margin of the
primary tumor [2]. Therefore, to improve our ability to treat patients
with malignant gliomas, we must increase our understanding of the
migratory and invasive properties of these tumors [3].
Invasion is a complex cellular phenomenon that involves cell-to-cell
and cell-to-extracellular matrix (ECM) interactions, enzymatic deg-
radation of the ECM, and cell migration [4]. Cell movement involves
the coordination of multiple signaling pathways that regulate cell-
substratum adhesion and actin cytoskeletal dynamics [5]. To migrate,
glioma cells must acquire a special polarized asymmetry. This enables
them to transform intracellular forces into net cell body translocation
[6]. Typically, a migrating glioma cell remodels its cytoskeleton and
forms protrusions and focal adhesions at the leading edge of the migra-
tory front. This generates contractile forces and traction, allowing the
cell body to move forward [7,8].
The small GTPase Rac1 is known to play a crucial role in the cyto-
skeletal and structural changes during cell migration and has been
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reported by our group and others to be amajor signaling node important
for the migration and invasion of glioma cells [9–14]. In a previous
study, we used gene expression profiling to identify guanine nucleotide
exchange factors (GEFs), which act on Rac proteins and which may be
important for glioma invasion. Three GEFs, namely, Trio, Ect2, and
Vav3, were selected for further study because their increased expression
was associated with poor patient outcome and higher tumor grade and
were shown to be important for glioma migration and invasion. To
further study the role of Rac-activating GEFs in human malignant
gliomas, we selected SWAP-70 as another candidate promigratory and
proinvasive gene from a data set of more than 26 Rac-activating GEFs
[15] because it ismore highly expressed in gliomas than in nonneoplastic
brain tissue. SWAP-70 is a 70-kDa protein originally isolated from
activated B lymphocytes [16] and is known to mediate lipid second
messenger signals to the cytoskeleton-organizing role of Rac.
SWAP-70 is widely expressed in various cell types and tissues
[16,17], and a high expression of SWAP-70 has been observed in acti-
vated B cells, immature mast cells, and B-cell neoplasms. SWAP-70
has been shown to regulate c-kit–induced mast cell activation, cell-cell
adhesion, and migration [18–21], but to date, no studies have reported
on the functional significance of SWAP-70 in human gliomas. Ac-
cordingly, in the present study, we have examined the role played by
SWAP-70 in the invasive phenotype of human glioma cells.
Materials and Methods
Expression Profile Data Set of Rho GEFS in Human
Gliomas and Nonneoplastic Brain
To identify candidate GEFs in human gliomas, we mined the
publicly available Repository for Molecular Brain N eoplasia Data
(REMBRANDT) gene expression microarray database containing
295 clinically annotated brain tumor specimens (National Cancer
Institute, 2005; REMBRANDT home page: <http://rembrandt.nci.
nih.gov>; accessed April 15, 2009). We specifically examined the gene
expression data from nonneoplastic brain (NB, n = 27), low-grade
astrocytomas (LGGs, n = 61), and glioblastoma multiformes (GBMs,
n = 147). Gene expression profiling and normalization was conducted
on all samples as previously described [15] (National Cancer Institute,
2005; REMBRANDT home page: <http://rembrandt.nci.nih.gov>;
accessed April 15, 2009).
Cell Lines and Cell Culture
The permanent, well-characterized U251, U343, U118, SNB19,
and T98 human glioma cell lines were maintained in Dulbecco’s modi-
fied Eagle’s medium (DMEM) with 10% fetal bovine serum (FBS;
HyClone Laboratories, Inc, Logan, UT). The U87 cell line was main-
tained in minimum essential medium supplemented with 10% FBS.
Cells were cultured in a 37°C, 5% carbon dioxide–humidified chamber.
Tissue Microarray and Immunohistochemistry
Immunohistochemical staining was done using the commercially
available brain tumor tissue microarray GL803 (US Biomax, Inc,
Rockville, MD), which consists of 55 astrocytic tumor specimens
and 5 normal brain specimens. The patient population included
22 male and 33 female tumor specimens, with a mean patient age of
41.7 years (range, 4-68 years), and 3 male and 2 female normal control
specimens, with a mean patient age of 45.8 years (range, 30-52 years).
Of the astrocytic tumor specimens, 6 were grade 1, 9 were grade 2,
25 were grade 3, and 15 were grade 4. Tumor grade data were pro-
vided by US Biomax, Inc, and determined according to the 2007
WHO grading system.
The tissues were deparaffinized, endogenous peroxidase activity was
blocked using 3% hydrogen peroxide in methanol, and microwave
antigen retrieval was achieved using Antigen Unmasking Solution
(Vector Laboratories, Inc, Burlingame, CA). Blocking was done using
10% normal horse serum, and endogenous biotin was blocked using
an avidin/biotin kit (Vector Laboratories). The tissue and tumor sec-
tions were incubated with a mouse monoclonal anti–SWAP-70 anti-
body (1:500; Abcam, Cambridge, MA) followed by a biotinylated
secondary antibody (Vector Laboratories) for 30 minutes, then a horse-
radish peroxidase–conjugated ultra-streptavidin labeling reagent (ID
Labs Biotechnology, Inc, London, Ontario, Canada) for 30 minutes.
After rinsing thoroughly in PBS, color development was performed
using freshly prepared NovaRED solution (Vector Laboratories). Fi-
nally, sections were counterstained lightly with Mayer hematoxylin,
dehydrated in alcohol, cleared in xylene, and mounted in Permount
(Fisher Scientific, Ottawa, Ontario, Canada).
SWAP-70 immunostaining was graded semiquantitatively using a
score ranging from 0 to 3 based on the extent of positive staining: 0 =
0%, 1 = 1% to 30%; 2 = 31% to 70%; and 3 ≥ 71% positive tumor
cells. Sections of normal human spleen were used as a positive control
for SWAP-70 immunoreactivity [22].
Western Blot Analysis
Whole cell lysates were prepared by harvesting cells in 50 mM
HEPES, pH 7.5, 150 mM NaCl, 1.5 mM MgCl2, 1% Triton X-100,
10% glycerol, and a complete cocktail of protease inhibitors (Roche
Molecular Biochemicals, Laval, Quebec, Canada). Protein concentra-
tions were determined using the Micro BCA kit (Pierce Biotechnology,
Rockford, IL) according to the manufacturer’s directions. Proteins
were separated by SDS-PAGE, transferred onto polyvinylidene fluoride
membrane (Immobilon-P; Millipore, Billerica, MA), and immuno-
blottedwith a goat polyclonal anti–SWAP-70 antibody (1:1000; Abcam)
or anti-FLAGM2mousemonoclonal antibody (1:1000; F3165; Sigma-
Aldrich, St Louis, MO) overnight at 4°C. A mouse monoclonal anti-
body against β-actin (1:1000; Sigma) or the human transferrin receptor
(1:1000; Zymed Laboratories, South San Francisco, CA) was used to
control for loading. Bound primary antibodies were visualized using
horseradish peroxidase–conjugated donkey antigoat or goat antimouse
immunoglobulin G antibodies (Bio-Rad Laboratories, Hercules, CA).
SWAP-70 Expression Construct and Transient Overexpressing
Cell Line
A plasmid containing full-length human SWAP-70 complementary
DNAwas obtained from the Mammalian Gene Collection (SWAP-70-
IRAU9-H2 in pOTB7). This complementary DNA was subcloned
into the pFLAG-CMV2 (Sigma) expression vector using polymerase
chain reaction cloning techniques to generate KpnI and BamHI restric-
tion sites. The sequence was then verified. Empty pFLAG-CMV2 was
used as a negative control. These constructs were transfected into the
U87 cell line using FuGene6 (Roche Applied Science) reagent. Western
blot was used to verify the protein expression level of SWAP-70 level
in the transfected cells.
Small Interfering RNA Preparation and Transfections
For gene silencing, a small interfering RNA (siRNA) quadriplex spe-
cific to SWAP-70 (NM_015055) ON-TARGETplus SMARTpool
(Dharmacon, Thermo Scientific, Waltham, MA) was purchased. The
Translational Oncology Vol. 2, No. 4, 2009 Role of SWAP-70 in Glioma Migration and Invasion Seol et al. 301
four target sequences were as follows: First sequence corresponds to
nucleotides 1902 to 1920 (5′ CAGGAGAGCTTTACGCTAA); the
second sequence corresponds to nucleotides 1725 to 1743 (5′ AGGAT-
TAATTCGACTGATA); the third corresponds to nucleotides 2591 to
2609 (5′ CCGAGTATGTGCTGTTAAA); and the fourth to nucleo-
tides 4317 to 4335 (5′ GCATAGTGTTACCGATTTA). A commer-
cial ON-TARGETplus nontargeting pool (Thermo Scientific) was used
to monitor off-target effects. Transient transfections were performed
with DharmaFect reagent (Thermo Scientific) according to the manu-
facturer’s protocol.
Immunofluorescence and Confocal Microscopy
Cells were plated onto coverslips 24 hours after transfection. At
72 hours after transfection, cells were washed three times with PBS
and fixed with 4% paraformaldehyde and 750 μl of 1 M sucrose for
30 minutes, then permeabilized for 10 minutes using 0.2% Triton
X-100 in PBS at room temperature. Nonspecific binding was blocked
by 5% BSA in PBS for 30 minutes at room temperature. Subsequently,
cells were incubated with goat polyclonal anti–SWAP-70 antibody
(1:100; Abcam) for 30 minutes in a 37°C incubator. After washing,
cells were then incubated with Alexa Fluor 488 (1:200; Molecular
Probes, Eugene, OR)–conjugated donkey antigoat immunoglobulin
G secondary antibody. For double labeling with F-actin, cells were
coincubated with Texas Red-X phalloidin (1:50; Molecular Probes).
To visualize fluorescence, a Zeiss Axiovert 200M Spinning Disk con-
focal microscope (Carl Zeiss Canada, Toronto, ON, Canada) equipped
with a Hamamatsu Back-Thinned EM-CCD camera (Hamamatsu
Corporation, Bridgewater, NJ) was used.
Treatment with 50 ng/ml epidermal growth factor (EGF) for
10 minutes induced membrane ruffling. After this, the morphologic
changes associated with the expression and/or localization of SWAP-70
were examined.
Cell Attachment Assay
The cell attachment assay was performed as described previously
[23,24] with some modifications. Briefly, 96-well plates were incubated
at 4°C overnight with different ECM proteins (laminin [LN] and fibro-
nectin [FN] at 10 μg/ml, and vitronectin [VN] at 1 μg/ml). The un-
bound sites were blocked with 0.1% BSA in PBS for 1 hour at 37°C.
Control dishes were prepared by blocking with BSA alone. Glioma cells
were detached 72 hours after transfection, resuspended in serum-free
medium then plated at 5 × 104 cells per well on ECM protein- or
BSA only coated plates. The cells were allowed to adhere for 3 hours
at 37°C and 5% carbon dioxide in a humidified chamber. Unattached
cells were removed by washing with PBS three times, and the remain-
ing cells were fixed with 4% paraformaldehyde and stained with 0.5%
crystal violet. Cells were destained with water then allowed to air-dry
overnight. The crystal violet bound to the attached cells was solubi-
lized with 1% SDS and measured the absorbance of each well was
measured at 595 nm using a microtiter plate reader (Molecular De-
vices, Sunnyvale, CA). All experiments were repeated three times with
five replicates.
Radial Cell Migration Assay
Cell migration assays were performed using the micrometer-scale ra-
dial monolayer assay as described previously [9,25,26]. Briefly, 10-well
Teflon-coated slides (CSM Inc, Phoenix, AZ) were coated with differ-
ent ECM proteins and 0.1% BSA as described above. To establish a
circular confluent monolayer at the center of the substrate-coated well,
transfected cells were collected 24 hours after transfection and seeded
through a cell sedimentation manifold (CSM Inc) at 2000 cells per
well. Photographs were acquired 22 hours after plating, and a circle
of best-fit circumscribing the cells was drawn representing the first time
point. The cells were allowed to migrate for 24 hours, then another
circle circumscribing the newly migrated cells was made. The average
migration rate was calculated as the change in the diameter of the circle
circumscribing the cell population during a 24-hour period (micro-
meters per 24 hours). Photomicrographs were taken with an inverted
microscope (Leica DM IRE2; Leica Microsystems, Inc, Bannockburn,
IL) and studied using an image analysis software (Scion Image, Frederick,
MD). All experiments were done in triplicate and repeated three times.
Transwell Cell Invasion Assay
A cell invasion assay was carried out using modified Boyden cham-
bers that consisted of Transwell-coated Matrigel membrane filter inserts
with 8-μm pores in 24-well tissue culture plates (BD Biosciences,
Bedford, MA) as described previously [26]. Two days after transfection,
4 × 104 cells were plated onto the top of the chamber in DMEM with
5% FBS. The bottom chamber was filled with DMEM containing
20% FBS as a chemoattractant. Plates were incubated for 24 hours
in a 5% carbon dioxide–humidified chamber at 37°C. Noninvading
cells were wiped off the upper surface of the membrane with a cotton
swab, and the filter membrane was fixed with 4% paraformaldehyde
and stained with 0.5% crystal violet. The degree of invasion was deter-
mined by counting the number of cells that had migrated through the
membrane in at least 6 random fields (total magnification, ×200) per
filter. Experiments were repeated three times in triplicate.
GTPase ELISA-Based Rac Activation Assay
For GTPase ELISA-based Rac activation, 5 × 104 U87 and T98 cells
were plated in six-well plates. Two days after transfection, cells were
serum-starved for 24 hours and then stimulated with EGF (10 ng/ml)
for 10 minutes. Cells were then washed twice with ice-cold PBS and
lysed in lysis buffer provided by the manufacturer. Equal aliquots of
lysate were used to interrogate Rac-GTP levels according to the manu-
facturer’s instructions (Cytoskeleton, Denver, CO).
Statistical Analyses
Statistical analyses were performed using Student’s t-test and the
Mann-Whitney U test. P < .05 was considered statistically significant.
Results
Increased Expression of SWAP-70 in High-grade Gliomas
Correlates with Poor Patient Outcome
To determine the expression of SWAP-70 in human gliomas, we re-
viewed a more recent version of the previous data set used to mine
GEFs in a recent report from our laboratory [15]. In this study, we used
data collected for REMBRANDT (http://rembrandt.nci.nih.gov).
Using this data set, we show that SWAP-70 (probe ID 209307_at)
has a significantly higher expression in GBMs compared with non-
neoplastic brain (P < .0001) and LGG (P = .0021). Statistical signifi-
cance was also achieved between SWAP-70 expression in LGG and NB
(P = .0112). Data are plotted as box plots of the median gene expression
ratios between the tumor sample and the geometric mean of nontumor
samples for the probe set selected in the query (Figure 1A). Given the
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Figure 1. Increasing SWAP-70 expression in glioma correlates with advanced disease and reduced survival. (A) Gene expression profiling
analysis for human SWAP-70.Messenger RNA expression levels of SWAP-70 from the data set are significantly increased in GBMs (n=147)
or LGG (n= 61) when compared with nonneoplastic brain (n= 27). Data were obtained from the REMBRANDT gene expression microarray
database containing 295 clinically annotated brain tumor specimens (National Cancer Institute, 2005; REMBRANDT home page: <http://
rembrandt.nci.nih.gov>; accessed April 15, 2009). (B) Kaplan-Meier survival curve of patient samples (n= 157) based on SWAP-70 expres-
sion. (C) Western blot analysis of SWAP-70 expression in glioma cell lines. U87 has the lowest SWAP-70 expression and was selected for
overexpression studies, and conversely, T98 and SNB19 express SWAP-70 at higher levels and were selected for subsequent RNA inter-
ference experiments. (D) Examination of SWAP-70 expression on tissue microarray. The tumors were immunostained for SWAP-70 mono-
clonal antibody and tested on positive control specimen (spleen, left panel). Tissuemicroarray sample of diffuse astrocytoma (WHO grade 2)
shows weak cytoplasmic staining, score 1. Anaplastic astrocytoma (grade 3) with moderate SWAP-70 reactivity, score 2. Glioblastoma with
strong staining in neoplastic cells, score 3 (right panel). Comparison of SWAP-70 expression in human gliomas showed statistically signifi-
cant differences in SWAP-70 gene expression when different tumor grades were examined (P = .001). Comparison between normal brain
and gliomas showed very significant high expression in gliomas (P= .0005). HGG showed higher expression level than LGG (P= .043; lower
panels). Anaplas. indicates anaplastic; astro, astrocytoma; HGG, high-grade glioma; LGG, low-grade glioma.
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strong correlation of SWAP-70 expression in high-grade gliomas, we
evaluated patient survival outcome based on SWAP-70 expression from
samples derived from the patient tumors. On plotting a Kaplan-Meier
survival curve, we observed significantly decreased survival times for
samples with more than two-fold increased SWAP-70 expression (n =
50) when compared with all other samples (log rank P value = 10−4).
Conversely, extended patient survival times for those samples with more
than two-fold decreased SWAP-70 expression was observed; however,
statistical significance was not achieved (P = .0506). This could be due
to a very small number of samples in this group (n = 4; Figure 1B).
Characterization of SWAP-70 Expression in Glioma Cell Lines
Western blot analysis to detect SWAP-70 protein expression was per-
formed on different glioma cell lines, including U343, U251, U118,
U87, SNB19, and T98. Cell lines demonstrated varying degrees of
SWAP-70 expression as observed in the Western blot (Figure 1C ).
From these results, we selected U87 for SWAP-70 overexpression ex-
periments given its low basal levels of SWAP-70. The T98 and SNB19
glioma cells lines were selected for gene silencing because these two cell
lines demonstrated abundant levels of SWAP-70.
Validation of SWAP-70 Expression in Primary Patient
Samples Using Tissue Microarray Analysis
Given the strong correlation of increased SWAP-70 transcript ex-
pression with increasing grade gliomas, we were interested in validating
Figure 2. Characterization of SWAP-70 localization in glioma cell lines.
(A) Redistribution of SWAP-70 after treatment of EGF. Glioma cells
expressing SWAP-70 were treated with or without EGF (50 ng/ml)
for 10 minutes and fixed with Alexa Fluor 488–conjugated donkey
antigoat antibody and Texas Red-X phalloidin to visualize F-actin
(red), followed by analysiswith confocalmicroscopy. SWAP-70 is en-
riched at the cortical membrane and membrane ruffles after EGF
stimulation (arrows). Arrows show staining for SWAP-70 at the lead-
ing edge in lamellipodia. (B) There was no change in total SWAP-70
protein expression levels after EGF treatment by Western blot
(lower panels). SW70 indicates SWAP-70; TfR, transferrin receptor.
Figure 3. Overexpression of SWAP-70 induces changes in cell mor-
phology. (A) U87 cells were selected for SWAP-70 overexpression
given the relatively low endogenous levels of SWAP-70 and tran-
sient transfection with pFLAG–SWAP-70. (Single band in pFLAG
lane is nonspecific cross-reacting protein that runs at a slightly lower
molecular weight than SWAP-70.) (B) SWAP-70 wasmainly localized
to the perinuclear cytoplasm and actin-rich membrane ruffles at the
leading edge (arrow) in serum-starved pFLAG-U87 cells. pFLAG–
SWAP-70 cells showed slightly increased membrane ruffles and re-
distribution of SWAP-70, even in serum-starved condition, and cells
appeared to have increased projections giving the cells a stellate
appearance. Scale bar, 10 μm. SW70 indicates SWAP-70.
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SWAP-70 gene expression at the protein level. We obtained a com-
mercially prepared tissue microarray consisting of 56 glioma samples
(grades 1 to 4) and 5 nonneoplastic controls. SWAP-70 immuno-
reactivity was significantly higher in high-grade gliomas (WHOgrades 3
and 4) than in low-grade gliomas (WHO grades 1 and 2; P = .043). In
addition, there is a significant difference in SWAP-70 expression when
nonneoplastic brain and gliomas were compared (P = .0001; Figure 1D,
lower panels). The comparison of SWAP-70 expression in different
grades of glioma revealed a direct correlation between protein levels
and increasing glioma grade (P = .001; Figure 1D, lower panels).
Cellular Redistribution of SWAP-70 after EGF
Stimulation and Alteration of Cell Morphology on
SWAP-70 Overexpression
Previously SWAP-70 was described to interact directly with F-actin
in COS-7 cells after EGF treatment [27]. Therefore, we examined the
localization of SWAP-70 in the context of glioma cells using immuno-
fluorescence before and after stimulation with EGF (Figure 2A).
Before EGF stimulation, SWAP-70 was distributed throughout the
cytosol, and after EGF treatment, SWAP-70 relocalized to the cell
periphery in subcortical regions of the cell. The cell lines used for
SWAP-70 knockdown studies, T98 and SNB19, shared similar cyto-
solic SWAP-70 distribution in unstimulated cells and relocalization to
cell cortex after EGF treatment (Figure W1). Western blot confirmed
that this change in SWAP-70 localization occurred without a change
in the expression levels of SWAP-70 (Figure 2B).
As described above, U87 glioma cells were transfected with FLAG–
SWAP-70 and assessed by Western blot analysis (Figure 3A). Exoge-
nous SWAP-70 was elevated in SWAP-70–transfected U87 glioma
cells compared with pFLAG empty vector controls. Overexpression of
SWAP-70 in U87 glioma cells did not cause a decrease in cell viability
whenmeasured at 24, 48, 72, and 96 hours after transfection in anMTS
cell growth assay (data not shown). In serum-starved U87 cells trans-
fected with the pFLAG empty vector control construct, SWAP-70
was mainly localized in the perinuclear cytoplasm and actin-rich mem-
brane ruffles at the leading edge of the cells. SWAP-70 overexpression
lead to cells having a more stellate morphology (Figure 3B).
SWAP-70 knockdown with a cocktail of four independent SWAP-70
siRNA sequences resulted in a significant decrease in SWAP-70 protein
levels within 48 hours after siRNA transfection (Figure 4A) and reached
maximum depletion at 72 hours (data not shown). No reduction in
SWAP-70 levels was observed with nontargeting siRNA controls. De-
pletion of SWAP-70 had no effect on cell viability in T98 or SNB19 cells
when measured by an MTS cell growth assay (data not shown). In
Figure 4. SWAP-70 knockdown alters glioma cell morphology. (A) T98 and SNB19 glioma cells were treated with either nontargeting or
SWAP-70 siRNA and SWAP-70 expression was assessed 72 hours after transfection. Greater than 80% knockdown was observed in
both cell lines. (B) The morphology of T98 (left panels) and SNB19 (right panels) glioma cells after SWAP-70 siRNA transfection tended to
be rounder and smaller and had a reduced number of membrane ruffles compared with nontargeting siRNA controls (left panels). si-NT
indicates non-targeting siRNA; si-SW70, siRNA-SWAP-70.
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siRNA-treated T98 (Figure 4B, left panels) and SNB19 (Figure 4B, right
panels) glioma cells, SWAP-70 depletion had modest effects on cell
morphology but cells tended to be rounder and smaller.
Modulation of SWAP-70 Expression Alters Glioma Cell
Adhesion to ECM
To further examine the importance of Rac-GEFs during the invasive
process of glioma cells, we selected SWAP-70 as another candidate
proinvasive gene in gliomas. We based our selection by virtue of its
grade-dependent increase in gene expression and its correlation to poor
survival. Accordingly, we conducted experiments to measure cell ad-
hesion, migration, and invasion when SWAP-70 is overexpressed or
depleted in glioma cells. Furthermore, we examined the varying effects
of different ECM proteins as a way to determine context-specific func-
tion, which may further lead us to clues to understanding the underly-
ing mechanisms mediating SWAP-70 function.
First, we performed a crystal violet cell attachment assay. The ad-
herence of U87 glioma cells to LN, VN, and FN was tested by plat-
ing U87 cells transfected with empty vector or FLAG–SWAP-70 onto
the appropriate ECM-coated substrates. Adhesion of empty vector–
transfected U87 cells was not enhanced on LN, VN, or FN above
that on BSA only. However, overexpression of SWAP-70 significantly
increased the adhesion of U87 glioma cells on both LN and FN
(Figure 5A, P = .001 and P = .006, respectively). In contrast, SWAP-70
knockdown in T98 cells inhibited glioma cell adhesion; however, only
cells on VN and not those on LN or FN further inhibited the ability
of cells to adhere (Figure 5B). SWAP-70 depletion in SNB19 cells had
virtually no difference on the adhesion of cells on BSA when compared
with NT control (P = .06). Although, in contrast to T98 cells, adhesion
on LN and FN was slightly more attenuated in the absence of SWAP-70
cells when compared with cells on BSA. Overall, these data show that
SWAP-70 has modest effects on cell adhesion, and the effects of ECM,
if any, vary by cell line.
SWAP-70 Expression Alters Glioma Migration and Invasion
To investigate whether SWAP-70 plays a role in the migratory pro-
cess of human glioma cells, we used radial migration assays with the
same ECM macromolecules as in the attachment assays described
above. As expected, the migration rate of all three glioma cell lines was
slightly to greatly enhanced when placed on ECM macromolecules.
In SWAP-70–transfected U87 glioma cells, the rate of migration was
increased on BSA by almost two-fold when compared with empty vec-
tor control. However, SWAP-70–transfected cells plated on LN or VN
resulted in a nearly three-fold increase in migration, whereas FN attenu-
ated the migration rate of these cells (Figure 6A). Although migration in
SWAP-70–depleted T98 cells was reduced nearly two-fold, migration
rate of these cells was decreased nearly six-fold on LN and three-fold
on VN (Figure 6B, upper panel ), but no added effect was seen on FN
when compared with cells on BSA. Similarly, in SNB19 glioma cells,
SWAP-70 knockdown decreased the migration rate on BSA by slightly
less than two-fold; however, migration was decreased by approximately
three-fold on LN and VN, but no added effect was seen on FN (Fig-
ure 6B, lower panel). Together, these data suggest that SWAP-70 is
required for enhanced cell migration on LNandVNbut is less important
for enhanced migration seen on FN. Therefore, signaling through LN
and VN proteins may be important components of the SWAP-70–
Rac signaling node.
Given that SWAP-70 plays a role in glioma cell adhesion and migra-
tion, we tested the effect of the modulation of SWAP-70 expression
on glioma invasion. In U87 that overexpressed SWAP-70, the cells
were more invasive through transwell filters than their parental counter-
part (P = .0005; Figure 6C ). Invasive potential decreased in SWAP-
70–depleted T98 cells (P = .009) and, similarly, in SNB19 in which
SWAP-70 was knocked down (P = .0003; Figure 6C ).
Role of SWAP-70 Expression on Rac Activation
Given that SWAP-70 is a Rac-GEF, we were interested in deter-
mining the effect of SWAP-70 on Rac activation levels in glioma cells.
To determine and compare the relative amounts of GTP-bound Rac in
the different glioma cell lines before and after EGF stimulation, we
measured active Rac with an ELISA-based method in SWAP-70 trans-
fected U87 glioma cells. In addition, SWAP-70 siRNA–transfected
T98 glioma cells and controls were measured in normal culture condi-
tions. Initially, the maximal activation of Rac was optimized using EGF
after 24 hours of serum starvation. In both U87 and T98 cells, the
maximum activation peak of active Rac was observed at 12 minutes
after treatment with 10 ng/ml EGF (Figure W2). Therefore, at this
time point, we measured the amount of GTP-bound Rac in normal
Figure 5. Effects of SWAP-70 expression on glioma cell adhesion.
(A) U87 cells overexpressing SWAP-70 or (B) T98 and SNB19 cells
transfected with SWAP-70 siRNAwere plated and allowed to adhere
for 3 hours at 72 hours after transfection. *P < .05, statistically sig-
nificant change in adhesion after modification of gene expression
levels. Columns represent the average optical absorbance of three
independent experiments. Bars, SE.
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Figure 6. Effects of SWAP-70 expression on glioma cell migration and invasion. Radial cell migration assays were performed on (A) U87
glioma cells overexpressing SWAP-70 or (B) T98 and SNB19 glioma cells transfected with SWAP-70 siRNA. Cells were transfected, then
48 hours after transfection, the cells were seeded and allowed to migrate for 24 hours. Images were acquired before and after migration,
and the average migration rate was calculated during 24 hours. *P < .05, significant changes in migration after transfection. (C) Matrigel
cell invasion assay in transient overexpressing and gene-silenced glioma cell lines. A modified Boyden chamber with Matrigel-precoated
membrane filter insert was used to measure in vitro invasiveness. At 24 hours after seeding the cells, the invading cells were fixed and
stained. Representative images are shown (left panels). Original magnification, ×200. Invasive cells were counted in six random fields.
Invasiveness was increased in U87 cells overexpressing SWAP-70. In contrast, the invasiveness was decreased in both T98 and SNB19
glioma cells in which SWAP-70 protein levels had been knocked down by RNA interference. *P < .05, significant changes in invasion after
modulation of SWAP-70 expression levels.
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culture conditions, in serum-starved cells, and in EGF-treated
cells (Figure 7). pFLAG–SWAP-70–transfected U87 cells showed a
3.5-times higher level of active Rac in serum-starved conditions than
pFLAG U87 cells did. In addition, the extent of increase after EGF
treatment was lower in pFLAG–SWAP-70–transfected cells: 4.83 in
pFLAG and 1.87 in pFLAG–SWAP-70, respectively (Figure 7A).
These findings suggest that Rac can be activated even in serum-starved
conditions if SWAP-70 is overexpressed. In SWAP-70–depleted T98
cells, Rac-GTP levels increased more than two-fold after EGF treat-
ment compared with nearly three-fold in nontargeting siRNA cells
(Figure 7B), indicating that depletion of SWAP-70 protein reduces
Rac activation in glioma cells.
Discussion
In this study, we show for the first time that the Rac-GEF SWAP-70
is an important mediator of glioma cell migration and invasion. The
expression of SWAP-70 was increased in gliomas when compared
with nonneoplastic brain, and this was correlated directly with in-
creasing grade of astrocytic malignancy and poor patient survival. Over-
expression of SWAP-70 in glioma cells increased adhesion to ECM,
migration, and invasiveness, whereas elimination of SWAP-70 ex-
pression by siRNA had the opposite effects. The results of our Rac
activation confirmed that SWAP-70 does indeed activate Rac and is
associated with growth factor–mediated membrane ruffle formation.
As a Rac-GEF, SWAP-70 has been shown to activate Rac and is
involved in signaling downstream of PI3-kinase–linked tyrosine kinase
receptors [28]. Among the signal pathways activated by growth fac-
tors, PI3-kinase and Rac play important roles in regulating membrane
ruffling. By stimulating tyrosine kinase receptors with growth factors,
active PI3-kinase catalyzes to produce PtdIns(3,4,5)P3. It has been
suggested that SWAP-70 acts as an effector or adaptor in response to
PI3-kinase activity and is therefore important in regulating the actin
cytoskeleton and cell motility by promoting PtdIns(3,4,5)P3–dependent
activation of Rac [17,21,27,28]. The colocalization and direct binding of
SWAP-70 with F-actin have been reported, especially when membrane
ruffling or Rac activation is induced by growth factors such as EGF
or platelet derived growth factor [27].
SWAP-70 contains an EF-hand motif at its N-terminal, a pleckstrin
homology domain at the center, and an extended coiled-coil region at
the C-terminal region [16,19]. Full-length SWAP-70 does not coloca-
lize with F-actin unless cells are stimulated with growth factors, which
suggests the presence of a stimuli-dependent regulatory mechanism for
actin-binding activity in vivo. Gene mutation studies by Ihara et al.
[27] showed that the binding and colocalization of SWAP-70 to F-actin
depends on the C-terminal region of SWAP-70. In addition, a study
by Wakamatsu et al. [29] revealed the crucial role that the pleckstrin
homology domain of SWAP-70 plays in facilitating the binding of
SWAP-70 to activated Rac through PtdIns(3,4,5)P3.
Previous studies have shown SWAP-70 to be expressed in various
tissues, such as heart, kidney, spleen, and liver [17]. Interestingly,
SWAP-70 is not expressed to any significant degree in the brain. Pre-
vious studies have demonstrated the translocation of SWAP-70 to
membrane ruffles by EGF [27,29]. The morphology and Western
blot studies performed in our study support the results of Ihara et al.
Shinohara et al. [28] showed that overexpression of SWAP-70 resulted
in an increase in activated Rac concentration. Previous studies have
suggested that SWAP-70 cooperates with activated Rac [17,21,
27,28]. Furthermore, SWAP-70 itself might increase the activation
of Rac and facilitate the recruitment of active Rac to the regions of
membrane ruffles.
In summary, in our study, a higher level of SWAP-70 was expressed
in malignant gliomas, including glioblastomas, than in normal brain.
In addition, through the use of gene manipulation studies, we have
shown that SWAP-70 alters glioma cell motility and invasion. These
results likely correlate with the level of GTP-bound activated Rac. Re-
cently, SWAP-70 was found to enhance the invasive phenotype of Src-
transformed mouse embryonic fibroblasts [30,31]. Without SWAP-70,
the Src-transformed mouse embryonic fibroblasts were found to be sig-
nificantly less invasive than their parental counterparts, and expression
of both SWAP-70 and Src induced constant membrane ruffling not
found with Src alone [31]. A study by Sharma and Mayer [32] found
that Src phosphorylates p130Cas resulting in specific activation of Rac1
and induction of membrane ruffling and migration events. Future
studies could include examination of this signaling complex to deter-
mine how the interaction of SWAP-70 and Rac relates to Src signaling
through p130Cas.
In addition, our future studies will examine how SWAP-70 functions
in vivo. To this end, it would be interesting to study mice harboring
intracranial gliomas derived from cell lines that have SWAP-70 expres-
sion knocked down or overexpressed and examine in vivo tumor growth
and invasiveness. SWAP-70 now joins the ranks of other GEFs, such
as Trio, ECT2, and Vav3, as important elements in the Rho-GTPase
pathway, which plays a role in glioma invasion and motility.
Figure 7. Rac1 activation assay in SWAP-70 transient-overexpressing
and gene-silencing cell lines. Glioma cells were harvested at the
optimized 12-minute time point after EGF treatment. The amount of
GTP-bound Rac of normal culturing cells, serum-starved cells, and
EGF-treatedcellswasmeasuredbyRac1ELISA.Upper number shows
the extent of increase after EGF treatment. (A) Rac1 could be acti-
vated even in serum-starved condition in SWAP-70–overexpressing
cell line. (B) In contrast, activation of Rac1 was inhibited in siRNA–
SWAP-70 cells compared with nonsilencing controls. EGF indicates
EGF treated after serum starvation; norm, normal culturing condition;
SS, serum starvation.
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Figure W1. Characterization of SWAP-70 localization in glioma cell
lines. Glioma cell lines T98 and SNB19 were either untreated or
treated with EGF and characterized by immunofluorescence as in
Figure 2. Figure W2. Optimization of Rac1 activation assay in glioma cell lines.
Different time points of 0, 1, 3, 6, 12, and 30 minutes under EGF
treatment were evaluated using GTP-Rac ELISA kit. U87 and T98
showed the maximal activation time point at 12 minutes after EGF
treatment. Absorbance was measured at 490 nm.
